Artificial Intelligence Has the Potential to Transform Clinical Trials, Study Says
According to a recent study on artificial intelligence (AI) by JAMA Cardiology, model applications show promise for improving the accuracy and speed of event classification in multicenter clinical trials. The study examined the potential for natural language processing (NLP) models to accurately classify heart failure (HF)...